WARDWIZARD (WARDHEALTH) | Financial Analysis & Statements
WARDWIZARD HEALTHCARE LIMITED Small-cap Financial Services
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.9M
Gross Profit
-808.4K
-41.62%
Operating Income
-4.7M
-242.10%
Net Income
-2.1M
-107.12%
EPS (Diluted)
₹-8.49
Balance Sheet Metrics
Total Assets
6.4M
Total Liabilities
42.0M
Shareholders Equity
-35.6M
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
WARDWIZARD Income Statement From 2024 to 2025
| Metric | 2025 | 2024 |
|---|---|---|
| Revenue | 4.2M | 1.1M |
| Cost of Goods Sold | 7.1M | 1.9M |
| Gross Profit | -2.9M | -831.0K |
| Gross Margin % | -70.1% | -74.9% |
| Operating Expenses | ||
| Research & Development | - | - |
| Selling, General & Administrative | 9.2M | 1.5M |
| Other Operating Expenses | 2.9M | 476.0K |
| Total Operating Expenses | 12.1M | 1.9M |
| Operating Income | -22.7M | -3.9M |
| Operating Margin % | -545.3% | -355.3% |
| Non-Operating Items | ||
| Interest Income | - | 0 |
| Interest Expense | 5.5M | 255.0K |
| Other Non-Operating Income | - | - |
| Pre-tax Income | -28.2M | -4.2M |
| Income Tax | -1.1M | 319.0K |
| Effective Tax Rate % | 0.0% | 0.0% |
| Net Income | -27.1M | -4.5M |
| Net Margin % | -650.6% | -404.1% |
| Key Metrics | ||
| EBITDA | -17.8M | -3.1M |
| EPS (Basic) | ₹-110.75 | ₹-18.31 |
| EPS (Diluted) | ₹-110.75 | ₹-18.31 |
| Basic Shares Outstanding | 245000 | 245000 |
| Diluted Shares Outstanding | 245000 | 245000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
WARDWIZARD Balance Sheet From 2024 to 2025
| Metric | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Current Assets | ||
| Cash & Equivalents | 275.0K | 187.0K |
| Short-term Investments | - | - |
| Accounts Receivable | 28.0K | 0 |
| Inventory | 1.6M | 0 |
| Other Current Assets | 1.0K | 1.0M |
| Total Current Assets | 3.5M | 1.4M |
| Non-Current Assets | ||
| Property, Plant & Equipment | 72.8M | 3.3M |
| Goodwill | 0 | 0 |
| Intangible Assets | - | - |
| Long-term Investments | - | - |
| Other Non-Current Assets | - | 1.0K |
| Total Non-Current Assets | 83.9M | 3.4M |
| Total Assets | 87.4M | 4.8M |
| Liabilities | ||
| Current Liabilities | ||
| Accounts Payable | 10.5M | 452.0K |
| Short-term Debt | 34.6M | 4.8M |
| Current Portion of Long-term Debt | - | - |
| Other Current Liabilities | 3.0M | 302.5K |
| Total Current Liabilities | 48.3M | 5.6M |
| Non-Current Liabilities | ||
| Long-term Debt | 69.8M | 3.2M |
| Deferred Tax Liabilities | 0 | 0 |
| Other Non-Current Liabilities | - | -1.0K |
| Total Non-Current Liabilities | 70.2M | 3.2M |
| Total Liabilities | 118.5M | 8.8M |
| Equity | ||
| Common Stock | 2.4M | 2.4M |
| Retained Earnings | -33.6M | -6.4M |
| Treasury Stock | - | - |
| Other Equity | - | - |
| Total Shareholders Equity | -31.1M | -4.0M |
| Key Metrics | ||
| Total Debt | 104.4M | 8.0M |
| Working Capital | -44.8M | -4.2M |
Balance Sheet Composition
WARDWIZARD Cash Flow Statement From 2024 to 2025
| Metric | 2025 | 2024 |
|---|---|---|
| Operating Activities | ||
| Net Income | -28.2M | -4.2M |
| Depreciation & Amortization | - | - |
| Stock-Based Compensation | - | - |
| Working Capital Changes | -9.3M | -852.0K |
| Operating Cash Flow | -32.0M | -4.8M |
| Investing Activities | ||
| Capital Expenditures | -79.0K | 0 |
| Acquisitions | - | 0 |
| Investment Purchases | - | - |
| Investment Sales | - | 0 |
| Investing Cash Flow | -79.0K | 0 |
| Financing Activities | ||
| Share Repurchases | - | - |
| Dividends Paid | - | - |
| Debt Issuance | 23.0M | 0 |
| Debt Repayment | - | - |
| Financing Cash Flow | 23.0M | 4.5M |
| Free Cash Flow | -16.4M | -3.7M |
| Net Change in Cash | -9.2M | -250.0K |
Cash Flow Trend
WARDWIZARD Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-0.41
Price to Book
-0.31
Price to Sales
1.20
PEG Ratio
0.01
Profitability Ratios
Profit Margin
-191.01%
Operating Margin
-104.61%
Return on Equity
87.16%
Return on Assets
-31.04%
Financial Health
Current Ratio
0.05
Debt to Equity
-0.85
Beta
0.46
Per Share Data
EPS (TTM)
₹-71.88
Book Value per Share
₹-145.25
Revenue per Share
₹37.63
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| WARDHEALTH | 11.1M | -0.41 | -0.31 | 87.16% | -191.01% | -0.85 |
| Motilal Oswal | 470.6B | 24.07 | 3.69 | 22.47% | 30.54% | 121.04 |
| Authum Investment | 426.1B | 11.72 | 2.62 | 28.87% | 110.11% | 20.29 |
| Delphi World Money | 48.7B | 73.72 | 0.65 | 2.21% | 0.30% | 2,547.19 |
| Indo Thai Securities | 39.0B | 106.49 | 17.17 | 4.56% | 56.96% | 1.43 |
| SG Finserve | 35.8B | 24.51 | 2.13 | 10.32% | 38.26% | 185.19 |
Financial data is updated regularly. All figures are in the company's reporting currency.




